Cordatus Wealth Management LLC Purchases Shares of 11,399 Relx Plc (NYSE:RELX)

Key Points

• Cordatus Wealth Management LLC purchased 11,399 shares of Relx Plc valued at approximately $575,000 as reported in their latest SEC filing.
• Multiple institutional investors, including Commonwealth Equity Services LLC and LPL Financial LLC, have recently increased their stakes in Relx, indicating growing investor interest.
• Relx has announced a semi-annual dividend of $0.2634, reflecting a dividend yield of 1.7% and a payout ratio of 65.05%.

Cordatus Wealth Management LLC purchased a new stake in shares of Relx Plc (NYSE:RELX - Free Report) in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 11,399 shares of the technology company's stock, valued at approximately $575,000.

Several other large investors have also made changes to their positions in RELX. Commonwealth Equity Services LLC boosted its holdings in Relx by 11.0% in the 4th quarter. Commonwealth Equity Services LLC now owns 17,761 shares of the technology company's stock valued at $807,000 after purchasing an additional 1,756 shares during the period. LPL Financial LLC raised its holdings in Relx by 20.9% in the 4th quarter. LPL Financial LLC now owns 230,589 shares of the technology company's stock valued at $10,473,000 after acquiring an additional 39,882 shares in the last quarter. Brown Brothers Harriman & Co. grew its holdings in shares of Relx by 218.5% during the 4th quarter. Brown Brothers Harriman & Co. now owns 965 shares of the technology company's stock worth $44,000 after purchasing an additional 662 shares in the last quarter. Franklin Resources Inc. increased its position in shares of Relx by 17.1% during the fourth quarter. Franklin Resources Inc. now owns 21,584 shares of the technology company's stock valued at $980,000 after purchasing an additional 3,155 shares during the period. Finally, HighPoint Advisor Group LLC bought a new stake in shares of Relx during the fourth quarter valued at approximately $199,000. Institutional investors and hedge funds own 15.02% of the company's stock.

Wall Street Analysts Forecast Growth

A number of research firms have weighed in on RELX. Morgan Stanley reiterated an "overweight" rating on shares of Relx in a research note on Wednesday, April 16th. Wall Street Zen raised shares of Relx from a "hold" rating to a "buy" rating in a research note on Saturday, July 26th. Five investment analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, Relx has a consensus rating of "Buy".

Relx Stock Performance

Shares of NYSE:RELX opened at $51.76 on Thursday. The company has a debt-to-equity ratio of 2.55, a current ratio of 0.47 and a quick ratio of 0.42. The business's fifty day moving average price is $53.45 and its two-hundred day moving average price is $51.45. Relx Plc has a fifty-two week low of $43.45 and a fifty-two week high of $56.33. The stock has a market capitalization of $95.07 billion, a price-to-earnings ratio of 27.83, a price-to-earnings-growth ratio of 3.39 and a beta of 0.83.

Relx Cuts Dividend

The company also recently announced a semi-annual dividend, which will be paid on Tuesday, September 16th. Stockholders of record on Friday, August 8th will be issued a $0.2634 dividend. This represents a dividend yield of 1.7%. The ex-dividend date of this dividend is Friday, August 8th. Relx's payout ratio is 65.05%.

Relx Company Profile

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.